Bio-Path Holdings Reports Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Bio-Path Holdings (BPTH) Misses Q2 EPS by 9c
August 15, 2023 7:01 AM EDTBio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.
... More